Search
for
Sort by
Research 961–990 of 1000+
- TREATMENT OF SEVERE ALOPECIA AREATA USING METHOTREXATE AS AN ADJUNCTIVE DRUG IN COMBINATION WITH INTRAVENOUS AND ORAL CORTICOSTEROID
- Self-adaptive nanozymes with enhanced multi-enzyme activities for sequential multimodal therapy of drug-resistant bacteria-infected wounds
- Bio-inspired suction cup microneedle loaded fusion membrane targeting nano-drug delivery system treat androgenetic alopecia
- Case report of Esophagus Squamous Cell Carcinoma treated with Novel Drug Preparation Method of Catheranthus rosea (Periwinkle) - An Integrated Oncological approach
- Female Serum HER2 Expression: Its Association With Metabolic Syndrome and Treatment Drug Response
- Using a Natural Clay Mineral as an Active Drug Carrier to Promote Hair Growth
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- Dutasteride infusion in male androgenetic alopecia using a novel drug delivery technique: MMP®
- Nanospanlastic vesicles as novel strategies for enhancing anti-glaucoma drug bioavailability
- Characterisation of Myotonic Dystrophy type I cell models and drug evaluation by a cell- based quantification platform.
- Cedrol in ginger (Zingiber officinale) as a promising hair growth drug: The effects of oral and external administration on hair regeneration and its mechanism
- 778 Designing and utilizing a c-Rel specific bioassay in drug repurposing screen for HNSCC
- A Top-Down Design Approach for Generating a Peptide PROTAC Drug Targeting Androgen Receptor for Androgenetic Alopecia Therapy
- Part I: Case series: Acute management of prescription and nonprescription drug overdoses
- A NEW GENERATION OF MARKERS FOR CANCER DETECTION AND DRUG TRANSPORT
- 1114 Study of long-term (15-day) imiquimod treatment and drug intervention in localized psoriasiform dermatitis model
- 1419 Pre-clinical in-vitro assays for high throughput screening of drug candidates for protection and restoration of immune privilege in alopecia areata
- Fractional carbon dioxide laser alone and as an assisted drug delivery for treatment of alopecia areata: a clinical, dermoscopic and immunohistochemical study
- Medication Clusters at Hospital Discharge and Risk of Adverse Drug Events at 30-days Post-Discharge: A Population-based Cohort Study of Older Adults
- Microgel emulsion loaded with recombinant oil body as a new drug delivery carrier to promote wound repair
- Image3_Neuropsychiatric Adverse Events of Montelukast: An Analysis of Real-World Datasets and drug−gene Interaction Network.TIFF
- A Simple Decision Tree Suited for Identification of Early Oral Drug Candidates With Likely Pharmacokinetic Nonlinearity by Intestinal CYP3A Saturation
- Adiantum capillus-veneris Linn (Maidenhair fern) extract-based drug as a symptomatic treatment for COVID-19. (clinical candidate)
- Product development and comparison of physio- chemical parameters of traditional drug recipe mentioned in Thalpathe pillium for hair growth
- A Smart Bandage Equipped with Miniaturized Needle Arrays and Wirelessly-Controlled Drug Delivery System for the Treatment of Chronic Wounds
- High-Dosed Intravenous Iron Replacement Therapy for Iron Deficiency Anemia Does Not Hinder Drug-Induced Amelioration of Disease Activity in IBD Patients
- P730 High-dosed intravenous iron replacement therapy does not hinder drug-induced amelioration of disease activity in IBD patients with iron deficiency anaemia
- Literature Review: Naltrexone: New Use for an Old Drug
- Identification of neprilysin as a potential target of arteannuin using computational drug repositioning
- - Tumor necrosis factor-alpha inhibitor associated psoriasiform alopecia (drug-induced psoriasiform alopecia)